Unitree Robotics Lists on China's STAR Market at 60.99B RMB Cap as First Humanoid Robot Stock

The Quick Take

• Unitree Robotics launched its STAR Market IPO at 150.80 RMB/share with a market cap of approximately 60.99 billion RMB
• The 'first humanoid robot stock' posted a record-low subscription rate for STAR Market, reflecting extreme oversubscription demand
• The 90-year-old entrepreneur-founded company drew a star-studded institutional investor consortium for strategic allotment

Unitree Robotics, described by Chinese financial media as the 'first humanoid robot stock' to list in China, completed its STAR Market IPO subscription process on August 12, 2026, with an issue price of 150.80 RMB per share and an issuance market capitalization of approximately 60.99 billion RMB. The IPO drew extraordinary investor demand: the online lottery subscription rate reached a new record low for the STAR Market, meaning winning a share allocation through the public lottery was exceptionally difficult — a sign of overwhelming retail and institutional demand. The company was founded by a young entrepreneur in their 30s and represents a milestone for domestic Chinese physical AI and robotics.

Unitree Robotics sits at the intersection of China's strategic priorities in advanced robotics, artificial intelligence, and industrial automation — sectors where Beijing has directed significant policy support and capital allocation as part of its Made in China 2025 and successor initiatives. The company's humanoid and quadruped robots have garnered international attention in demonstrations, competing with US-based counterparts from Figure AI, Boston Dynamics, and Agility Robotics. A successful IPO at a 60.99 billion RMB market cap provides Unitree with substantial public capital to accelerate R&D and manufacturing scale-up. The star-studded strategic investor consortium signals institutional confidence in the company's trajectory.

Key forward signals after the IPO include Unitree's first quarterly earnings as a listed company, which will reveal revenue recognition patterns and the commercial scale of humanoid robot deployments. Investors should watch for any order announcements from major Chinese manufacturing or logistics customers, which would validate the company's transition from demonstration-stage to revenue-generating commercial deployments. The macro variable is China's manufacturing automation adoption rate — the pace at which Chinese factories incorporate humanoid and quadruped robots determines whether Unitree's addressable market expands at the rates implied by its listing valuation. Any US export controls targeting Chinese robotics AI chips could also create technology procurement headwinds.

Synthesized from 2 sources.